A polymorphism in the CYP17 gene is associated with prostate cancer risk.
about
CYP17 polymorphisms and prostate cancer outcomes.Genetic variation: effect on prostate cancer.Lignans and human health.Hormones and prostate cancer: current perspectives and future directions.Pharmacogenetics of human androgens and prostate cancer--an update.Common genetic polymorphisms and prognosis of sporadic cancers: prostate cancer as a model.CYP17 T27C polymorphism and prostate cancer risk: a meta-analysis based on 31 studiesEthnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.Genetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF-1, and IGFBP-3 and prostate cancer risk in African-American men: the Flint Men's Health Study.Molecular mechanisms involving prostate cancer racial disparity.Human genetic variation: new challenges and opportunities for doping control.Genetic architecture of acne vulgaris.Identification of novel SNPs associated with risk and prognosis in patients with castration-resistant prostate cancer.Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation.Molecular basis for prostate cancer racial disparities.Association of Polymorphisms in the VDR, CYP17 and SRD5A2 Genes and Prostate Cancer Among Lebanese MenPolymorphisms of glutathione-S-transferase genes (GSTP1, GSTM1 and GSTT1) and prostate-cancer risk.Impact of genetic polymorphisms of 17-hydroxylase cytochrome P-450 (CYP17) and steroid 5alpha-reductase type II (SRD5A2) genes on prostate-cancer risk among the Japanese population.Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways.Quantitative assessment of the association between CYP17 rs743572 polymorphism and prostate cancer risk.Allelic frequencies of six polymorphic markers for risk of prostate cancer.Association of polymorphisms within androgen receptor, 5alpha-reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men.Comprehensive evaluation of the association between prostate cancer and genotypes/haplotypes in CYP17A1, CYP3A4, and SRD5A2.Association between hormonal genetic polymorphisms and early-onset prostate cancer.Molecular mechanisms involving prostate cancer racial disparity.Genotyp des GNB3-C825T-Polymorphismus
P2860
Q33884273-F40EDD14-D209-4E4C-AF74-67BCBC552527Q34663656-1C1EDFFA-E8E2-4325-8949-AFB65D9642BFQ34702636-70D8DE54-DD45-4522-82E3-97F864CD6ABFQ34732880-FC0DDCE0-C35F-4DE9-A9DB-11EAB43DB197Q35753329-1C581BE9-0E87-4931-93D6-0BE2A12BF3E6Q36430744-05F6890C-B0C5-48E2-93C1-4D8ECB3D96EEQ36681449-E8AF14AB-3AF8-4A38-8BCB-916A529C748AQ36758880-4BE405DD-89E0-4AAC-9E56-27FC33F8961EQ37267225-8D0DC34F-7814-4FD0-81FC-97E0524AB748Q37418937-7F81A314-C0EE-4426-A737-A2B56D0E2199Q38017318-67830731-CA70-45BE-A16F-598318B9D8E2Q38736949-CFF3CDE9-5D5A-4ECA-8DD8-4DC8D750AA28Q39156588-5C8A22E5-B7AC-4DDC-8308-767DD97418A4Q40837890-D6177D45-838B-453B-8965-A7EAF5D8D0E3Q41334556-FEB6DA82-7EDF-4E97-9F9E-DA34C9C147F8Q41461592-6B649A72-4976-4CFC-A87F-2C626F73E5B9Q43578597-BA25418B-B89D-49A1-A850-350179CCE138Q43599642-403C63F4-DC2A-47B2-9232-954E07543BCDQ43747296-81C1FF5E-09FF-4CC1-9EB8-D42464A18C2DQ43845691-BA34F653-E0DE-4619-8E13-A8CBD051D2A4Q43888278-28B69337-FB22-4FA0-89CE-DEB44898DEB6Q44059679-A4294F6B-2445-4C54-BE97-8F647945630BQ44618467-5712AFF4-9D5C-4813-9D76-0278A5C24A13Q45265466-615C0A8F-6175-4F95-8CB2-4495959587E5Q45327318-FFA7B2D0-5564-4E64-A0F6-1C310A4E4CE4Q57395708-5841EE30-332A-49DD-91DA-C3B10F3D7CD7
P2860
A polymorphism in the CYP17 gene is associated with prostate cancer risk.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
A polymorphism in the CYP17 gene is associated with prostate cancer risk.
@en
A polymorphism in the CYP17 gene is associated with prostate cancer risk.
@nl
type
label
A polymorphism in the CYP17 gene is associated with prostate cancer risk.
@en
A polymorphism in the CYP17 gene is associated with prostate cancer risk.
@nl
prefLabel
A polymorphism in the CYP17 gene is associated with prostate cancer risk.
@en
A polymorphism in the CYP17 gene is associated with prostate cancer risk.
@nl
P2093
P2860
P1476
A polymorphism in the CYP17 gene is associated with prostate cancer risk.
@en
P2093
G Bernhofer
G Haidinger
M Marberger
M Micksche
S Hinteregger
S Madersbacher
P2860
P304
P356
10.1002/1097-0215(20000801)87:3<434::AID-IJC19>3.0.CO;2-G
P577
2000-08-01T00:00:00Z